Get started
Author

Pascal d’Azemar

Observed names: DAZEMAR, P, P D'Azemar, P D’Azemar, P d'Azemar, P d'Azémar, P d’Azemar, P. d'Azemar, P. d’Azemar, P. d’Azémar, Pascal D'Azemar, Pascal d'Azemar
Observed institutions: Hôpital Necker-Enfants Malades, Sanofi (France), Centre Hospitalier Universitaire de Lille, Lille’s Cardiology Hospital, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôtel-Dieu de Paris, Centre Hospitalier Universitaire de Liège, Hôpital Purpan
OpenAlex ID: A5069585697
Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
1996 · Maria M.W. Koopman, Paolo Prandoni, et al. · New England Journal of Medicine · 1,100
PDF
Systematic Lung Scans Reveal a High Frequency of Silent Pulmonary Embolism in Patients With Proximal Deep Venous Thrombosis
2000 · Michel Meignan, Jean Rosso, et al. · Archives of Internal Medicine · 244
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery
1996 · M T Nurmohamed, A M van Riel, et al. · Thrombosis and Haemostasis · 240
Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin)
1998 · P. Mismetti, S. Laporte-Simitsidis, et al. · Thrombosis and Haemostasis · 92
Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
1992 · C Théry, G Simonneau, et al. · Circulation · 88
PDF
Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis
1998 · Bernard A. Charbonnier, Jean-Noël Fiessinger, et al. · Thrombosis and Haemostasis · 85
Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study
2005 · I. Mahé, J. F. Bergmann, et al. · European Journal of Clinical Pharmacology · 76
Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty
1997 · Jean-Marc Lablanche, Eugène P. McFadden, et al. · Circulation · 48
Pharmacodynamics of CY 216 in healthy volunteers: inter‐individual variations
1990 · M Rostin, JL Montastruc, et al. · Fundamental and Clinical Pharmacology · 11
[Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
1990 · G Steinbach, C Bosc, et al. · PubMed · 8
Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216
1990 · J. Diéval, P. Morinière, et al. · Thrombosis Research · 3
A randomized trial of subcutaneous low molecular weight heparin CY 216 D (fraxiparineR) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism (a dose-ranging study)
1992 · G. Simonneau, C. Thery, et al. · Thrombosis Research · 1
Inter-individual Pharmacokinetic Variations After Intravenous (iv) and Subcutaneous (sc) Injection of Cy 216 in Healthy Subjects
1987 · B Boneu, G Houin, et al. · Thrombosis and Haemostasis · 1
[Theoretical advantages of combined H1 and H2 blockade for premedication in general anaesthesia (author's transl)].
1981 · P d'Azémar · PubMed · 1
Prévention et Traitement de L'accident Vasculaire Cérébral Ischémique par les Antithrombotiques et les Thrombolytiques
2009 · Pascal d'Azemar · Elsevier eBooks
Liste des Collaborateurs
2009 · Antoine Achkar, Pascal D'Azemar, et al. · Elsevier eBooks
[Should the pharmaceutical industry play an active part in pharmacosurveillance? (author's transl)].
1980 · P d'Azemar, C Alexandre, et al. · PubMed
Works count: 18
Citation count: 1,998
H-index: 9
I10-index: 9
Year
Topic
Type